RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES
Impact
If passed, H8382 will amend Section 5-19.1-35 of Rhode Island's General Laws concerning pharmacies. It specifically addresses the conditions under which audits can occur, limiting the frequency of on-site audits to one per carrier every twelve months unless substantial evidence of wrongdoing is suspected. This amendment is aimed at preventing unnecessary disruptions to pharmacy operations and ensuring that any findings of overpayment or underpayment are based on actual rather than projected data.
Summary
House Bill H8382 is an act aimed at strengthening the enforcement of the state's pharmacy audit laws by enhancing and clarifying audit procedures. The bill seeks to ensure that pharmacy audits are conducted fairly and transparently, which includes stipulations on how such audits should be carried out, notification procedures, and the rights of pharmacies during the audit process. The overall intent is to protect pharmacies from unreasonable audit practices while ensuring compliance with state regulations.
Contention
The bill may face points of contention primarily around its enforcement provisions. While supporters argue that it rightly protects pharmacies from arbitrary and overly aggressive audit practices, critics may express concerns regarding the implications for accountability in cases of suspected fraud or abuse. The bill gives the Rhode Island attorney general authority to enforce compliance, which, while viewed positively as a check on audit practices, raises questions about the balance between regulatory oversight and protecting businesses from excessive scrutiny.
Restricts audits of pharmacists conducted by insurers and their intermediaries, limiting audits to one per year unless an identified problem exists or fraud or misrepresentation is suspected.
Restricts audits of pharmacists conducted by insurers and their intermediaries, limiting audits to one per year unless fraud or misrepresentation is reasonably suspected. The RI attorney general has the authority to impose sanctions for violations.
Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals".
Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals."
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.